Correlation of prostate-specific antigen nadir and biochemical failure after high-intensity focused ultrasound of localized prostate cancer based on the Stuttgart failure criteria - analysis from the @-Registry-Reference-Cited by-同舟云学术

Correlation of prostate-specific antigen nadir and biochemical failure after high-intensity focused ultrasound of localized prostate cancer based on the Stuttgart failure criteria - analysis from the @-Registry

Published:2011-02-18 Issue:8b Volume:108 Page:E196-E201
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:

Author:

Ganzer Roman,Robertson Cary N.,Ward John F.,Brown Stephen C.W.,Conti Giario N.,Murat Francois J.,Pasticier Gilles,Rebillard Xavier,Thuroff Stefan,Wieland Wolf F.,Blana Andreas

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.2011.10091.x/fullpdf

Reference20 articles.

1. PSA nadir is a significant predictor of treatment failure after high-intensity focussed ultrasound (HIFU) treatment of localised prostate cancer;Ganzer;Eur Urol,2008

2. To what extent does the prostate-specific antigen nadir predict subsequent treatment failure after transrectal high-intensity focused ultrasound therapy for presumed localized adenocarcinoma of the prostate?;Uchida;BJU Int,2006

3. Treatment of prostate cancer with transrectal focused ultrasound: early clinical experience;Gelet;Eur Urol,1996

4. Local control of prostate cancer by transrectal high intensity focused ultrasound therapy: preliminary results;Gelet;J Urol,1999

5. Transrectal high-intensity focused ultrasound: minimally invasive therapy of localized prostate cancer;Gelet;J Endourol,2000

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oncological and Functional Outcomes of Whole-Gland HIFU as the Primary Treatment for Localized Prostate Cancer: A Systematic Review;Clinical Genitourinary Cancer;2024-08

2. Focal high‐intensity focused ultrasound therapy for localized prostate cancer: An interim analysis of the multinational FASST study;European Journal of Clinical Investigation;2024-03-06

3. Primary Whole-gland Ablation for the Treatment of Clinically Localized Prostate Cancer: A Focal Therapy Society Best Practice Statement;European Urology;2023-12

4. Single-Center Evaluation of Treatment Success Using Two Different Protocols for MRI–Guided Transurethral Ultrasound Ablation of Localized Prostate Cancer;Frontiers in Oncology;2021-10-27

5. Focal therapy for localized prostate cancer in the era of routine multi-parametric MRI;Prostate Cancer and Prostatic Diseases;2020-02-12